Search Results - Romana Netea-Maier
- Showing 1 - 5 results of 5
-
1
-
2
-
3
Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice by Jaume Capdevila, Desiree’ Deandreis, Cosimo Durante, Sophie Leboulleux, Markus Luster, Romana Netea-Maier, Kate Newbold, Susanne Singer, Gerasimos P Sykiotis, Beate Bartes, Kate Farnell, Laura Deborah Locati
Published in European Thyroid Journal (2023-08-01)Get full text
Article -
4
Extracellular vesicle-associated transcriptomic and proteomic biomarkers show in vitro potential for vandetanib treatment monitoring in anaplastic thyroid cancer by Christian Grätz, Prashant Changoer, Dapi Menglin Chiang, Johannes Kersting, Martin Jaeger, Romana Netea-Maier, Susanne I. Wudy, Christina Ludwig, Markus List, Benedikt Kirchner, Marlene Reithmair, Michael W. Pfaffl
Published in Scientific Reports (2025-09-01)Get full text
Article -
5
Patient decision aids for patients with differentiated thyroid carcinoma: development process and alpha and beta testing by Anna Koot, Anna Koot, Rosella Hermens, Petronella Ottevanger, Romana Netea-Maier, Peep Stalmeier, the COMBO study group, Marieke Snel, Noortje van der Kleij-Corssmit, Johannes Bonenkamp, Koen Dreijerink, Evelien van Dam, Grard Nieuwenhuijzen, Mariel Keemers, Lieke Welling, Iris van der Ploeg, Sanne Engelen, Danielle Dercks, Frans Geenen
Published in Frontiers in Endocrinology (2023-05-01)Get full text
Article
